Tony T Kalajian's Net Worth

$17.5 Thousand

Estimate Recalculated Jul 3, 2024 08:02PM EST

Who is Tony T Kalajian?

Tony T Kalajian does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Oncocyte Corp, and Calidi Biotherapeutics, Inc..

SEC CIK

Tony T Kalajian's CIK is 0001786237

Past Insider Trading and Trends

2020 was Tony T Kalajian's most active year for acquiring shares with 2 total transactions. Tony T Kalajian's most active month to acquire stocks was the month of January. 2019 saw Tony T Kalajian paying a total of $19,800.00 for 10,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Oncocyte Corp (OCX) Snapshot price: $2.9201

Sr.VP/Chief Accounting Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+50.00%
5K
$1.31
$6,533.00
15K
Aug 3
Form 4
—
0
—
—
0
Feb 10
Form 4
∞
10K
$1.98
$19,800.00
10K
Sep 13
Form 3
—
0
—
—
0
No matching records found

Calidi Biotherapeutics, Inc. (CLDI) Snapshot price: $0.6252

Chief Acctg Officer, Int. CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found